ModuleMD shows AI documentation, front-desk agents and skin-test measurement for allergy EHR
At ACAAI 2026 the allergy EHR maker showed WISE Touch AI, a 75-language documentation tool, five front-office agents and image-based skin-test measurement.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
At ACAAI 2026 the allergy EHR maker showed WISE Touch AI, a 75-language documentation tool, five front-office agents and image-based skin-test measurement.
The trust's Lung Cancer Digital Avatar Project, powered by OcciAI and funded by MSD, explains tests and appointments to patients with suspected lung cancer in up to 10 languages.
OpenAI is rolling out Health in ChatGPT to Android, the desktop app, Sites and dots. Its help page says conversations that reference connected health data now follow the user's model improvement setting.
GPT-6.2 Astra earned 84.5% of the credit across 99 problems, but OpenAI says the results do not show models can discover new drugs.
NEA led the Series A for the UC Berkeley spin-out, whose Med-BEAM model predicts the care patients are likely to need next.
The US health system joined Layer Health's Series A as a strategic investor and will run more than a dozen registries on its software.
The Korea Consumer Agency also found ChatGPT and Perplexity pointed users to sites selling drugs banned from online sale.
Bessemer led the Series A for the London-based MIT spinout, which works with Pfizer, GSK, Takeda and Bristol Myers Squibb.
The Belgian startup's 30-second face scan gives six health measures, and it plans to bring the technology to humanoid robots.
Oman's sovereign wealth fund joins the round for the Suzhou company, which serves more than 500 pharma and research customers.
Texas A&M researchers screened more than 630,000 protein pairs and confirmed several of the predicted pairings in the lab.
MarcyPen leads the equity part and General Catalyst provides $200 million in growth financing; Gwyneth Paltrow's Kinship also invests.
Perplexity Fund and IQT back the San Diego start-up, which reprocesses old proteomics experiments to find missed results.
The deal pairs Novo's clinical trial data with nference's AI platform and includes a framework for new AI-native ventures.
A Journal of Cardiac Failure study found adding AI analysis of one echocardiogram clip to a clinical score caught 78% of confirmed HFpEF cases, against 48% for the score alone.
The Dallas AI company adds Form Bio's genetic medicine design tools; both companies came out of Colossal Biosciences.
The Rx Assistant unveiled Builder at HLTH 2026, letting pharmaceutical brands deploy AI experiences for patients and healthcare professionals across voice, SMS, email and chat.
Physicians rated 99% of 325 reviewed GPT-6 Astra tasks safe; CVS Health cleared a months-long backlog over a weekend.
From November 16, new FDA documents use 'Super Intelligence' and 'SI'; the agency says the change creates no new requirements for companies.
Scribes have commoditised as EHR vendors move in, while drug discovery, clinical copilots and patient engagement grow fastest.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.